EcoDrugPlus

Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 8

Ensembl ID : ENSORLG00000026393
Gene Symbol: CACNG8
4 Cross references
159 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 A

Ensembl ID : ENSORLG00000011019
Gene Symbol: CACNA1A
4 Cross references
186 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 D

Ensembl ID : ENSORLG00000003397
Gene Symbol: CACNA1D
4 Cross references
208 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 H

Ensembl ID : ENSORLG00000008618
Gene Symbol: CACNA1H
3 Cross references
208 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSORLG00000011460
Gene Symbol: CNR1
4 Cross references
150 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSORLG00000014779
Gene Symbol: CNR2
4 Cross references
191 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSORLG00000007332
Gene Symbol: CA12
4 Cross references
214 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSORLG00000005650
Gene Symbol: CA6
4 Cross references
215 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSORLG00000011256
Gene Symbol: CA4A
4 Cross references
212 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSORLG00000002507
Gene Symbol: CA4C
4 Cross references
79 Possible Orthologues:

Carbonic Anhydrase Vii

Ensembl ID : ENSORLG00000028995
Gene Symbol: CA7
4 Cross references
221 Possible Orthologues:

Carbonic Anhydrase Va

Ensembl ID : ENSORLG00000012594
Gene Symbol: CA5A
4 Cross references
231 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).